Palatrigine

TargetMol
Product Code: TAR-T24588
Supplier: TargetMol
CodeSizePrice
TAR-T24588-1mg1mg£135.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24588-5mg5mg£215.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24588-10mg10mg£279.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24588-25mg25mg£477.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24588-50mg50mg£617.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24588-100mg100mg£848.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24588-500mg500mg£1,621.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Palatrigine is a chemically novel agent that exhibits in a single molecule both angiotensin-converting enzyme inhibition and beta-adrenoceptor-blocking properties.
CAS:
98410-36-7
Formula:
C12H13Cl2N5
Molecular Weight:
298.17
Pathway:
GPCR/G Protein|Neuroscience|Metabolism
Purity:
0.98
SMILES:
CC(C)n1nc(-c2cccc(Cl)c2Cl)c(=N)nc1N
Target:
Adrenergic Receptor|Angiotensin-converting Enzyme (ACE)

References

1. Allan G, Donoghue S, Follenfant MJ, Sawyer DA. BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents. Br J Pharmacol. 1986 Jun;88(2):333-43. PubMed PMID: 3730698; PubMed Central PMCID: PMC1916834. 2. Donoghue S, Payne PN, Allan G. Effects of BW A256C, a novel class 1 antiarrhythmic agent, on maximum rate of depolarisation of cardiac action potentials in vitro: frequency, use, and voltage dependence. J Cardiovasc Pharmacol. 1987 Jan;9(1):12-8. PubMed PMID: 2434786. 3. Allan G, Cambridge D, Hardy GW, Follenfant MJ. BW A575C, a chemically novel agent with angiotensin converting enzyme inhibitor and beta-adrenoceptor-blocking properties. Br J Pharmacol. 1987 Mar;90(3):609-15. PubMed PMID: 2882805; PubMed Central PMCID: PMC1917187.